Corbus Pharmaceuticals Valuation
| CRBP Stock | USD 17.47 0.74 4.42% |
At this time, the firm appears to be undervalued. Corbus Pharmaceuticals shows a prevailing Real Value of $30.46 per share. The current price of the firm is $17.47. Our model approximates the value of Corbus Pharmaceuticals from analyzing the firm fundamentals such as Current Valuation of 57.02 M, return on equity of -0.51, and Shares Owned By Insiders of 0.70 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Corbus Pharmaceuticals' valuation include:
Price Book 1.4138 | Enterprise Value 57 M | Enterprise Value Ebitda 0.1697 | Price Sales 163.3187 | Enterprise Value Revenue 8.2564 |
Undervalued
Today
Please note that Corbus Pharmaceuticals' price fluctuation is somewhat reliable at this time. Calculation of the real value of Corbus Pharmaceuticals is based on 3 months time horizon. Increasing Corbus Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Corbus Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 17.47, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.47 | Real 30.46 | Target 71.0 | Hype 17.78 | Naive 21.33 |
The intrinsic value of Corbus Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Corbus Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Corbus Pharmaceuticals Holding helps investors to forecast how Corbus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Corbus Pharmaceuticals more accurately as focusing exclusively on Corbus Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Corbus Pharmaceuticals' intrinsic value based on its ongoing forecasts of Corbus Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Corbus Pharmaceuticals' closest peers.
Corbus Pharmaceuticals Cash |
|
Corbus Valuation Drivers Correlation
Many accounts on the financial statements of Corbus Pharmaceuticals are highly interrelated and sometimes correlated. Consequently, when conducting Corbus's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Corbus
Click cells to compare fundamentals
Corbus Valuation Trend
Corbus Pharmaceuticals' real value is important for investors to make better decisions and a more accurate overall view of Corbus Pharmaceuticals' financial worth over time. Using both Corbus Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Corbus Pharmaceuticals Total Value Analysis
Corbus Pharmaceuticals Holding is currently forecasted to have valuation of 57.02 M with market capitalization of 212.78 M, debt of 20.88 M, and cash on hands of 66.23 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Corbus Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
57.02 M | 212.78 M | 20.88 M | 66.23 M |
Corbus Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Corbus is to check how much profit was generated for every dollar of assets it reports. Corbus Pharmaceuticals Holding shows a negative utilization of assets of -0.29 percent, losing $0.002882 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Corbus Pharmaceuticals Holding shows how discouraging it operates for each dollar spent on its assets.Corbus Pharmaceuticals Ownership Allocation
The majority of Corbus Pharmaceuticals Holding outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Corbus Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Corbus Pharmaceuticals. Please pay attention to any change in the institutional holdings of Corbus Pharmaceuticals Holding as this could imply that something significant has changed or is about to change at the company.Corbus Pharmaceuticals Profitability Analysis
Net Loss for the year was (44.6 M) with loss before overhead, payroll, taxes, and interest of (16.14 M).About Corbus Pharmaceuticals Valuation
The stock valuation mechanism determines Corbus Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Corbus Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Corbus Pharmaceuticals. We calculate exposure to Corbus Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Corbus Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -31.2 M | -29.6 M | |
| Pretax Profit Margin | (59.53) | (56.55) | |
| Operating Profit Margin | (73.03) | (69.37) | |
| Net Loss | (59.41) | (56.44) | |
| Gross Profit Margin | (0.77) | (0.81) |
Corbus Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Corbus Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.3 M |
Corbus Pharmaceuticals Current Valuation Indicators
Corbus Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Corbus Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Corbus Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Corbus Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Corbus Pharmaceuticals' worth.Additional Tools for Corbus Stock Analysis
When running Corbus Pharmaceuticals' price analysis, check to measure Corbus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corbus Pharmaceuticals is operating at the current time. Most of Corbus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corbus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corbus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corbus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.